Tag: celg

4 Stocks That Deserve Your Attention In 2019

| January 16, 2019 | 0 Comments
4 Stocks That Deserve Your Attention In 2019

We’ve heard numerous times that the stock market isn’t looking too hot, especially going into 2019. Many top fund managers, investors, and CEOs believe have expressed concerns over the United States slipping into a recession, likely by the end of this year. What could cause such a downturn and make top money-makers nervous of what’s to […]

Continue Reading

6 Undervalued Stocks With Strong Upcoming Catalysts

| November 4, 2016 | 0 Comments
6 Undervalued Stocks With Strong Upcoming Catalysts

If all goes well for these six stocks, over the next year they could be worth significantly more than what currently trade for. Each stock has important, business-defining events that, if positive, would make their businesses much more valuable. “Uncertainty is the only certainty there is, and knowing how to live with insecurity is the […]

Continue Reading

Earnings Report Card: Stocks To Buy & Sell

| August 1, 2016 | 0 Comments
Earnings Report Card: Stocks To Buy & Sell

Stocks look like they will extend their profit recession for a fifth quarter in a row, but not all stocks reported lower earnings. Bret Jensen shares which stocks and sectors that he is bullish on and those that he wants to avoid for the time being. The markets keep grinding up and hitting all-time highs […]

Continue Reading

4 Undervalued Stocks To Buy And 5 Overvalued Stocks To Sell

| July 13, 2016 | 0 Comments
4 Undervalued Stocks To Buy And 5 Overvalued Stocks To Sell

Now that we’re at the half point of 2016, Bret Jensen identifies the best and worst areas to put your money for the rest of the year. Plus Bret gives you his favorite stocks in each of those sectors along with five stocks facing significant headwinds. It is hard to believe we are already in […]

Continue Reading

Biotech Stocks: Stem Cell Stocks Rallying On Court Decision

| May 2, 2011 | 0 Comments

Stem cell stocks have been on a roller coaster ride over the past nine months.  They’ve plunged… soared… plunged again… and now they could be gearing up for another climb. Investors need an iron stomach, or a lot of Pepto Bismol, to survive this ride. But in the end it could be well worth it.  […]

Continue Reading